| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121490 | Journal of Clinical Virology | 2013 | 6 Pages |
Abstract
The validated second-generation JCV antibody ELISA offers improved assay design as a kit and enhanced performance characteristics that advance routine clinical use of the assay as a PML risk stratification tool.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Peter Lee, Tatiana Plavina, Albert Castro, Melissa Berman, Dipeshkumar Jaiswal, Suzanne Rivas, Brian Schlain, Meena Subramanyam,